Long-Lasting Remission of Severe Behcet's Disease After the End of Infliximab Therapy

Journal of Rheumatology - Canada
doi 10.3899/jrheum.081063
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Journal of Rheumatology

Related search

Drug-Free Long-Term Remission in Severe Behcet's Disease Following Withdrawal of Successful Anti-TNF Treatment

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Prediction of Relapse After Discontinuation of Infliximab Therapy in Severe Sarcoidosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

Long-Term Safety Study of Infliximab in Moderate-To-Severe Chronic Obstructive Pulmonary Disease

Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Complete Regression of Retinal Neovascularisation After Therapy With Interferon Alfa in Behcet's Disease

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2000English

Recurrence of Cushing's Disease After Long-Term Remission Due to Pituitary Apoplexy.

Endocrine Journal
EndocrinologyMetabolismDiabetes
2000English

Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients With IBD After Discontinuation of One-Year Infliximab Therapy

PLoS ONE
Multidisciplinary
2014English

Remission of Cap Polyposis Maintained for More Than Three Years After Infliximab Treatment

Gut and Liver
HepatologyGastroenterology
2009English

Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

Open Access Macedonian Journal of Medical Sciences
Medicine
2019English

Long-Term Remission of Severe Refractory Dermatopolymyositis With a Weekly-Scheme of Immunoglobulin Followed by Rituximab Therapy

Rheumatology International
RheumatologyAllergyImmunology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy